Detalhe da pesquisa
1.
Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer.
Cancer Cell;
42(5): 869-884.e9, 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38579725
2.
Spatiotemporal role of SETD2-H3K36me3 in murine pancreatic organogenesis.
Cell Rep;
43(2): 113703, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38265933
3.
Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma.
J Transl Int Med;
11(4): 322-329, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38130635
4.
Clostridium butyricum and its metabolite butyrate promote ferroptosis susceptibility in pancreatic ductal adenocarcinoma.
Cell Oncol (Dordr);
46(6): 1645-1658, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37261698
5.
The diverse pancreatic tumor cell-intrinsic response to IFNγ is determined by epigenetic heterogeneity.
Cancer Lett;
562: 216153, 2023 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37023939
6.
Tumor Cell-Intrinsic SETD2 Deficiency Reprograms Neutrophils to Foster Immune Escape in Pancreatic Tumorigenesis.
Adv Sci (Weinh);
10(2): e2202937, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453584
7.
Glycolysis addiction compensating for a defective pentose phosphate pathway confers gemcitabine sensitivity in SETD2-deficient pancreatic cancer.
Biochem Biophys Res Commun;
615: 9-16, 2022 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35679751
8.
SULF2 enhances GDF15-SMAD axis to facilitate the initiation and progression of pancreatic cancer.
Cancer Lett;
538: 215693, 2022 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35472437
9.
Ketogenesis acts as an endogenous protective programme to restrain inflammatory macrophage activation during acute pancreatitis.
EBioMedicine;
78: 103959, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35339899